Status:
COMPLETED
Food Effect Study For Apixaban Commercial Image Tablets
Lead Sponsor:
Pfizer
Conditions:
Healthy
Eligibility:
All Genders
21-45 years
Phase:
PHASE1
Brief Summary
To evaluate the effect of food on the pharmacokinetics of apixaban administered as commercial image tablets.
Eligibility Criteria
Inclusion
- Healthy volunteers
Exclusion
- History or evidence of abnormal bleeding or coagulation disorder (eg, easy bruising or gingival bleeding, prolonged bleeding after dental extraction, postpartum, or after trauma, wounds or surgery) and/or having a first degree relative under 50 years of age with a history of abnormal bleeding or coagulation disorder
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT01437839
Start Date
September 1 2011
End Date
October 1 2011
Last Update
October 25 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Singapore, Singapore, 188770